Showing results (11-20 of 32) with videos related to
Sort By:
Pageof 4
Breast Cancer Research and Treatment|March 23, 2019
Vinorelbine plus Capecitabine (Vinocap): a retrospective analysis in heavily pretreated HER2 negative metastatic breast cancer patientsAlfredo Torres, Jeremy L Ramdial, Luis E Aguirre, et al.Journal of Medical Case Reports|December 12, 2022
Multiple receptor conversions during the course of metastatic breast cancer therapy: a case report and review of the literatureYolcar Chamorro, Ana C Sandoval-Leon, Charles L Vogel, et al.Breast Cancer Research and Treatment|June 27, 2002
Weekly paclitaxel in women age 65 and above with metastatic breast cancerEdith A Perez, Charles L Vogel, David H Irwin, et al.Annals of Surgical Oncology|May 3, 2002
Focused microwave phased array thermotherapy for primary breast cancerRobert A Gardner, Hernan I Vargas, Jerome B Block, et al.Breast Cancer Research and Treatment|September 12, 2015
Survival of patients with de-novo metastatic breast cancer: analysis of data from a large breast cancer-specific private practice, a university-based cancer center and review of the literatureSimon B Zeichner, Stuart Herna, Aruna Mani, et al.Pain|May 21, 2019
Testing a positive-affect induction to reduce verbally induced nocebo hyperalgesia in an experimental pain paradigmAndrew L Geers, Shane Close, Fawn C Caplandies, et al.Clinical Breast Cancer|September 3, 2005
Evaluation of clinical outcomes according to HER2 detection by fluorescence in situ hybridization in women with metastatic breast cancer treated with trastuzumabRobert D Mass, Michael F Press, Steven Anderson, et al.Clinical Breast Cancer|October 9, 2007
Feasibility and cardiac safety of pegylated liposomal doxorubicin plus trastuzumab in heavily pretreated patients with recurrent HER2-overexpressing metastatic breast cancerEleni Andreopoulou, Darci Gaiotti, Eugene Kim, et al.Breast Cancer Research and Treatment|June 6, 2014
A retrospective study evaluating a fixed low dose capecitabine monotherapy in women with HER-2 negative metastatic breast cancerTadeu Ambros, Simon B Zeichner, John Zaravinos, et al.Breast Cancer : Basic and Clinical Research|April 30, 2015
Defining the survival benchmark for breast cancer patients with systemic relapseSimon B Zeichner, Tadeu Ambros, John Zaravinos, et al.Pageof 4